Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

NovoCure Limited

NVCR•NASDAQ
Healthcare
Medical - Instruments & Supplies
$11.08
$-0.31(-2.70%)
U.S. Market is Open • 14:36

NovoCure Limited (NVCR) Stock Overview

Explore NovoCure Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.3B
P/E Ratio-7.11
EPS (TTM)$-1.61
ROE-0.50%
Fundamental Analysis

AI Price Forecasts

1 Month$7.83
3 Months$3.70
1 Year Target$3.64

NVCR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of NovoCure Limited (NVCR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.34, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.64.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.11 and a market capitalization of 1.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.26%
5-Day Change
-9.41%
1-Month Change
-12.75%
3-Month Change
-0.87%
6-Month Change
-3.57%
Year-to-Date (YTD) Change
-13.41%
1-Year Change
-47.53%
3-Year Change
-85.94%
5-Year Change
-93.73%
All-Time (Max) Change
-48.36%

Contact Information

https://www.novocure.com
44 15 3475 6700
No. 4 The Forum, Saint Helier, NaN, JE2 4UF

Company Facts

14,880 Employees
IPO DateOct 1, 2015
CountryJE
Actively Trading

Frequently Asked Questions